McAndrew: No Reason Not to Start With CDK4/6 Inhibitors in Metastatic HR+ HER2-Negative Breast Cancer
AJMC,
The American Journal of Managed Care® (AJMC®) recently spoke with Nicholas McAndrew, MD, MSCE, a medical oncologist and breast…
The American Journal of Managed Care® (AJMC®) recently spoke with Nicholas McAndrew, MD, MSCE, a medical oncologist and breast…
Nicholas Patrick McAndrew MD, MSCE Since 1971, after Cole et al reported activity of tamoxifen in patients with late-stage…
Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan…